Aktie A2JFPK BBS-BIOACTIVE BONE SUBSTITUTES OYJ
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen BBS-Bioactive Bone Substitutes Oyj

Aktien

A2JFPK

FI4000260583

BONEH

Markt geschlossen - Nasdaq Helsinki
Andere Börsenplätze
 18:00:00 26.06.2024 		% 5 Tage % 1. Jan.
0,349 EUR -0,29 % Intraday Chart für BBS-Bioactive Bone Substitutes Oyj -0,29 % -28,63 %
13.06. BBS-Bioactive Bone Substitutes Oyj stimmt der Wahl von Gregor Siebert als neues Mitglied des Verwaltungsrats zu CI
04.06. BBS-Bioactive Bone Substitutes Plc gibt die Genehmigung der ergänzenden Patentanmeldung für das Produkt ARTEBONE® bekannt CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Municipality of Reisjärvi
BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Finha Capital Oy
BBS-Bioactive Bone Substitutes Plc plans a share issue to strengthen its equity and will advance the publication date of its half-year report
BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Panvest Oy
BBS-Bioactive Bone Substitutes Plc: Decisions of the Annual General Meeting 2024
BBS-Bioactive Bone Substitutes Oyj Approves Election of Gregor Siebert as New Member to the Board of Directors
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
BBS-Bioactive Bone Substitutes Plc: Claims of the complementary patent application for the ARTEBONE® product have been approved in the USA
BBS-Bioactive Bone Substitutes Plc Announces Approval of Complementary Patent Application for the ARTEBONE® Product
Notice to the BBS-Bioactive Bone Substitutes Plc’s Annual General Meeting
BBS-Bioactive Bone Substitutes Plc Announces Ahti Paananen Not Available for Re-Election to the Board of Directors
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024
BBS-Bioactive Bone Substitutes – Insider information: The company updates the status of the CE marking process
BBS-Bioactive Bone Substitutes Plc: Annastiina Kauppinen appointed as Financial Manager of BBS-Bioactive Bone Substitutes Plc
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
BBS-Bioactive Bone Substitutes Plc: The website's functionality restored
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2JFPK Aktie
  4. Nachrichten BBS-Bioactive Bone Substitutes Oyj
  5. Andere Sprachen